The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(5-Fluoro-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrimidin-4-yl)-2-isopropyl-3,4-dihydroisoquinolin-1(2H)-one ID: ALA5205035
PubChem CID: 168297332
Max Phase: Preclinical
Molecular Formula: C25H28FN7O
Molecular Weight: 461.55
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)N1CCc2cc(-c3nc(Nc4ccc(N5CCNCC5)cn4)ncc3F)ccc2C1=O
Standard InChI: InChI=1S/C25H28FN7O/c1-16(2)33-10-7-17-13-18(3-5-20(17)24(33)34)23-21(26)15-29-25(31-23)30-22-6-4-19(14-28-22)32-11-8-27-9-12-32/h3-6,13-16,27H,7-12H2,1-2H3,(H,28,29,30,31)
Standard InChI Key: UBHPJEJMHASIRC-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
-3.5565 -0.0045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5565 0.8204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8448 1.2311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1358 0.8208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1358 -0.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8430 -0.4109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4240 -0.4117 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7122 -0.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7122 0.8209 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0021 1.2300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7113 0.8189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4215 1.2299 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.7113 0.0012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0024 -0.4135 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4231 -0.4096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1350 0.0010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8443 -0.4092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5563 0.0017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2683 -0.4092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2683 -1.2313 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5563 -1.6423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8443 -1.2313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1368 -1.6415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4231 -1.2350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5563 -2.4642 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.2683 1.2315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9800 0.8204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.6917 1.2315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.6917 2.0533 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9800 2.4642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2683 2.0533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9800 -1.6422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6917 -1.2313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9800 -2.4641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 3 1 0
5 4 2 0
1 6 2 0
6 5 1 0
5 7 1 0
7 8 1 0
9 8 2 0
10 9 1 0
11 10 2 0
11 12 1 0
13 11 1 0
8 14 1 0
14 13 2 0
13 15 1 0
16 15 2 0
17 16 1 0
17 18 1 0
19 18 1 0
20 19 1 0
21 20 1 0
22 17 2 0
22 21 1 0
23 22 1 0
15 24 1 0
24 23 2 0
21 25 2 0
2 26 1 0
27 26 1 0
28 27 1 0
29 28 1 0
30 29 1 0
31 30 1 0
26 31 1 0
20 32 1 0
32 33 1 0
32 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 461.55Molecular Weight (Monoisotopic): 461.2339AlogP: 3.24#Rotatable Bonds: 5Polar Surface Area: 86.28Molecular Species: BASEHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.81CX Basic pKa: 8.87CX LogP: 3.40CX LogD: 1.93Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.60Np Likeness Score: -1.17
References 1. Chen W, Ji M, Cheng H, Zheng M, Xia F, Min W, Yang H, Wang X, Wang L, Cao L, Yuan K, Yang P.. (2022) Discovery, Optimization, and Evaluation of Selective CDK4/6 Inhibitors for the Treatment of Breast Cancer., 65 (22.0): [PMID:36350721 ] [10.1021/acs.jmedchem.2c00947 ]